Please join us at the latest instalment of the Wright-Fleming Institute Infection and Immunity Seminar Series.

About the speaker

Michelle Linterman is Group Leader at the Babraham Institute, Cambridge. Her laboratory aims to understand the cellular and molecular basis of the germinal centre response, which generates robust humoral immunity after vaccination and infection. The Linterman lab is funded by the Bioscience and Biotechnology Research Council and the European Research Council. Michelle is currently an EMBO Young Investigator, a Lister Institute Prize Fellow and a Fellow of Churchill College.

Michelle received her PhD in Immunology from the Australian National University in Canberra, where she investigated the contribution of the germinal centre response to humoral autoimmunity with Prof. Carola Vinuesa. Michelle undertook post-doctoral research with Prof. Ken Smith at the University of Cambridge, where she described a population of suppressive regulatory T cells that localise to, and function within, the germinal centre reaction.